These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6386588)

  • 1. Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.
    Sasaki K; Nagai M; Kato H; Torigoe T; Nagamine Y; Takahashi M
    Gan; 1984 Aug; 75(8):703-6. PubMed ID: 6386588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytofluorometric analysis for screening cervical squamous cell carcinoma using specific antibody to a tumor antigen TA-4].
    Nagai M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):612-6. PubMed ID: 6715941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
    Kato H; Nagaya T; Torigoe T
    Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of tumor antigen TA-4 in cervical cytologic specimens.
    Suehiro Y; Kato H; Nagai M; Torigoe T
    Cancer; 1986 Apr; 57(7):1380-4. PubMed ID: 2418939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
    Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
    Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
    Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunocytochemical detection of antigen associated with squamous cell cancer of the cervix uteri in women].
    Ievleva ES; Marshutina NV; Ageenko AI; Tsukerman BG
    Eksp Onkol; 1990; 12(4):65-7. PubMed ID: 2199188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
    Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
    Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
    J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
    Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
    Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant induction of tumor-associated antigen, TA-4 and chorionic gonadotropin beta in cultured cervical carcinoma cells.
    Maruo T; Matsuo H; Nishino R; Hussa RO; Strobel JL; Pattillo RA; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Feb; 39(2):291-6. PubMed ID: 3493311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma.
    Senekjian EK; Young JM; Weiser PA; Spencer CE; Magic SE; Herbst AL
    Am J Obstet Gynecol; 1987 Aug; 157(2):433-9. PubMed ID: 3475982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment and characterization of TA-4 producing cell line (OMC-1) originating from a human squamous cell carcinoma of the uterine cervix].
    Ueda M; Maeda T; Yamada T; Miyawaki Y; Otsuki Y; Okamoto Y; Okamura S; Sano T; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1071-8. PubMed ID: 3746026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
    Kato H; Morioka H; Tsutsui H; Aramaki S; Torigoe T
    Cancer; 1982 Oct; 50(7):1294-6. PubMed ID: 7104971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistological evaluation of the cancer associate antigen (TA-4) for pathoclinical management of the cervical malignancy].
    Kimura A; Shibata K; Hoshina M; Maruo T; Mochizuki M
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2248-54. PubMed ID: 6533207
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.
    Nelson DS
    Clin Exp Immunol; 1974 Jan; 16(1):53-62. PubMed ID: 4619779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
    Kato H; Morioka H; Aramaki S; Tamai K; Torigoe T
    Am J Obstet Gynecol; 1983 Feb; 145(3):350-4. PubMed ID: 6824024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.